Introduction: Emerging evidence suggests that young and middle-aged adults may experience postacute sequelae of COVID-19, increasing their risk of cardiovascular complications. However, it remains unclear whether these risks translated into higher all-cause mortality. Methods: We analysed mortality and population data from 16 European countries to estimate excess mortality among individuals aged 20-64 years during the period 2020-2024. Excess mortality was defined as the difference between observed and expected age-standardised mortality rates. Expected values were modelled using three approaches based on different assumptions: (1) a long-trend linear model based on 2010-2019 data; (2) a non-linear model using the same baseline and (3) a short-trend linear model based on 2015-2019 data. Results: In 2020 and 2021, all models consistently estimated substantial excess mortality in several countries, with the highest estimates in 2021 for Bulgaria (34.7%-37.3% in males, 45.1%-51.6% in females), Hungary (21.0%-28.9% in males, 30.7%-35.4% in females), Poland (19.1%-24.1% in males, 23.6-24.0 in females) and Slovakia (32.1%-36.6% in males, 34.2%-38.1% in females). In 2022, model estimates diverged, with significant excess mortality persisting only under the long-trend linear model. By 2023, residual excess mortality was found only among males in Austria (according to the long-trend linear and non-linear models) and Finland (according to the long-trend linear model), while in 2024 persisted only in Austria under the same models. Assuming a continuing linear mortality trend appeared to overestimate excess mortality in some age groups. Conclusions: Our analysis indicates substantial excess mortality among adults aged 20-64 in 2020 and in 2021 in Europe but does not support a sustained postpandemic increase in all-cause mortality. The estimates were sensitive to the choice of the baseline period and modelling approach, underscoring the importance of presenting results under multiple analytical assumptions.
Excess mortality at ages 20-64 from 2020 to 2024: a comparative analysis of 16 European countries / G. Alicandro, A.G. Gerli, C. La Vecchia. - In: BMJ PUBLIC HEALTH. - ISSN 2753-4294. - 3:2(2025 Nov), pp. 1-11. [10.1136/bmjph-2025-003328]
Excess mortality at ages 20-64 from 2020 to 2024: a comparative analysis of 16 European countries
G. Alicandro
Primo
;A.G. Gerli;C. La VecchiaUltimo
2025
Abstract
Introduction: Emerging evidence suggests that young and middle-aged adults may experience postacute sequelae of COVID-19, increasing their risk of cardiovascular complications. However, it remains unclear whether these risks translated into higher all-cause mortality. Methods: We analysed mortality and population data from 16 European countries to estimate excess mortality among individuals aged 20-64 years during the period 2020-2024. Excess mortality was defined as the difference between observed and expected age-standardised mortality rates. Expected values were modelled using three approaches based on different assumptions: (1) a long-trend linear model based on 2010-2019 data; (2) a non-linear model using the same baseline and (3) a short-trend linear model based on 2015-2019 data. Results: In 2020 and 2021, all models consistently estimated substantial excess mortality in several countries, with the highest estimates in 2021 for Bulgaria (34.7%-37.3% in males, 45.1%-51.6% in females), Hungary (21.0%-28.9% in males, 30.7%-35.4% in females), Poland (19.1%-24.1% in males, 23.6-24.0 in females) and Slovakia (32.1%-36.6% in males, 34.2%-38.1% in females). In 2022, model estimates diverged, with significant excess mortality persisting only under the long-trend linear model. By 2023, residual excess mortality was found only among males in Austria (according to the long-trend linear and non-linear models) and Finland (according to the long-trend linear model), while in 2024 persisted only in Austria under the same models. Assuming a continuing linear mortality trend appeared to overestimate excess mortality in some age groups. Conclusions: Our analysis indicates substantial excess mortality among adults aged 20-64 in 2020 and in 2021 in Europe but does not support a sustained postpandemic increase in all-cause mortality. The estimates were sensitive to the choice of the baseline period and modelling approach, underscoring the importance of presenting results under multiple analytical assumptions.| File | Dimensione | Formato | |
|---|---|---|---|
|
Excess Mortality 20-64.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
1.54 MB
Formato
Adobe PDF
|
1.54 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




